Middle East and Africa Biopharmaceutical Tubing Market is expected to reach US$ 226.70 million by 2028

PRESS RELEASE BY The Insight Partners 03 Aug 2021

Share this press on

The silicone segment by type is estimated to lead the market growth during the forecast period.

According to The Insight Partners market research study of “Middle East and Africa Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Application and Country.” The Middle East and Africa biopharmaceutical tubing market is expected to reach US$ 226.70 million by 2028 from US$ 136.34 million in 2021; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.  The report highlights trends prevailing in the Middle East and Africa biopharmaceutical tubing market and the factors driving market along with those that act as hindrances.

Popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing. Also, growing use of platinum-cured silicone as material of choice for biopharmaceutical tubing offers several advantages over traditional peroxide cured tubing. For instance, in January 2020, Watson-Marlow Fluid Technology Group (WMFTG) launched BioPure silicone transfer tubing to confer safe, reliable, and cost-effective solution for a wide range of bioprocess fluid transfer applications. Therefore, the launch and use of platinum-cured silicone tubing as a material of choice is likely to emerge as a significant trend in the biopharmaceuticals market during the forecast period. Thus, there are significant opportunities for the market players to enter the market with superior and cost-effective products.

The COVID-19 pandemic has become the most significant challenge in the Middle East region. This challenge would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq, Sudan, Israel, and Yemen, because it will result in reduced imports due to global trade disruptions, which will exacerbate shortage of medical supplies and other goods, resulting in significant rise in price. However, the biopharmaceutical tubing market in this pandemic is on rising due to the demand for medical devices that incorporate tubing in the region.

The Middle East and Africa biopharmaceutical tubing market, by type, is segmented into plastic, metal, and silicone. Based on application, the Middle East and Africa biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. Geographically, Middle East and Africa biopharmaceutical tubing market can be segmented into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.

W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc, Optinova, NORDSON CORPORATION and DuPont de Nemours, Inc. are among the leading companies operating in the Middle East and Africa biopharmaceutical tubing market.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com 

Download Free PDF Brochure